Di (2-ethyl hexyl) phthalate and its metabolite-induced metabolic syndrome: a review of molecular mechanisms

Sorour Ashaari,Tannaz Jamialahmadi,Neal M. Davies,Wael Almahmeed,Amirhossein Sahebkar
DOI: https://doi.org/10.1080/01480545.2024.2405830
2024-09-27
Drug and Chemical Toxicology
Abstract:Objectives Metabolic disorders, as multifactorial disorders, are induced by genetic susceptibility and exposure to environmental chemicals. Di (2-ethyl hexyl) phthalate (DEHP), a ubiquitous plasticizer, is well known as an endocrine-disrupting chemical in living organisms. In recent decades, researchers have focused on the potential of DEHP and its main metabolite (Mono (2-ethylhexyl) phthalate) (MEHP) to induce metabolic disorders. In the present review, we aimed to summarize studies regarding DEHP and MEHP-induced Metabolic syndrome (MetS) as well as address the involved mechanisms.
pharmacology & pharmacy,toxicology,chemistry, multidisciplinary
What problem does this paper attempt to address?